Genomics and Precision Health Posts
Workings of an Evidence-Based Genomic Panel
Synopsis of the 24th Meeting of the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group The EGAPP working group (EWG) has held 24 meetings in the 7 years since they were first convened; the latest EGAPP meeting was May 7-8, 2012 on the campus of CDC in Atlanta. Since it is Read More >
Posted on bySharing the Burden of Obesity
On May 7-9, the CDC Division of Nutrition, Physical Activity, and Obesity, hosted a conference on Weight of the Nation™ in Washington, D.C. The conference served to highlight progress in the prevention and control of obesity through policy and environmental strategies. The Weight of the Nation is also the title of an HBO Documentary Read More >
Posted on by 1 CommentGenomic Tests and Population Health: An Online Catalog to Promote a Conversation on Evolving Evidence
With the rapid emergence of genomic tests, healthcare providers, patients and policy makers need to know how useful they are and whether the benefits of their use outweigh potential harms to patients, families, and the population. CDC’s Office of Public Health Genomics now offers a list of health-related genomic tests and applications, stratified into Read More >
Posted on by 4 CommentsSmoke Screen…
Never Let Genetics Blind You to the Harsh Reality of Cigarettes The emerging field of genomics might one day provide some tools to help address the smoking epidemic. However, smokers should never think that their genes can protect them from devastating harms or provide an easy way for them to quit later. In 2012, Read More >
Posted on byUshering Public Health Practice into the 21st Century
The April 2012 special issue of the journal Public Health Genomics includes 13 articles from the many presentations at the 4th National Conference on Genomics and Public Health in the United States: “Using Genetic Information to Improve Health Now and In the Future”. The three-day conference sponsored by the Centers for Disease Control and Prevention, Read More >
Posted on byEvidence Matters in Genomic Medicine
A new IOM report makes recommendations that aim to ensure that progress in omics-based test development is grounded in sound scientific evidence and is reproducible, resulting in improved health care and continued public trust in research. Another new IOM roundtable workshop report discussed the differences in evidence required for clinical use, regulatory oversight, guideline inclusion, coverage, Read More >
Posted on by 1 CommentMaking Universal Screening for Lynch Syndrome a Reality: The Lynch Syndrome Screening Network
Every day, about 400 people in the United States are diagnosed with colorectal cancer. Approximately twelve of them have Lynch syndrome, a hereditary condition that increases the risk of colorectal cancer and other cancers. Identifying people with Lynch syndrome could have substantial health benefits for them, their families, and communities. Read More >
Posted on by 1 CommentThe Public Health Approach to Genetic Testing in the 21st Century: Saving Lives and Saving Unnecessary Healthcare Costs
In March 2012, a prominent health insurer in the United States released a white paper entitled: “Personalized Medicine: trends and prospects for the new science of genetic testing and molecular diagnostics” By analyzing their own claims data, the report suggests that in 2010, the cost of genetic and molecular diagnostic testing for its members was about $500 Read More >
Posted on by 4 CommentsCan Sudden Cardiac Death of the Young be Prevented?
A Michigan Story on Lessons Learned and Action Steps to Take The winter months have arrived and with them comes a certain madness, specifically March Madness. On March 12, 2012 the NCAA men’s college basketball tournament will commence. Most of the focus will be on cheering for the teams we picked to win our brackets; Read More >
Posted on by 5 CommentsEmerging Evidence for the Benefits of Systematic Collection of Family History in Primary Care
When it comes to the use of genomic tests and technologies in practice, Dr Al Berg is a skeptic. Dr Berg is the founding chair of the CDC-sponsored Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group that has been evaluating genomic tests for more than 5 years. He also chaired the National Institutes Read More >
Posted on by 3 Comments